Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer? Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011
Evaluation of the medical knowledge degree about clinical suspicion of pulmonary thromboembolism (PTE) Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006
Clinical implications of incidental venous thromboembolism in cancer patients Source: Eur Respir J, 55 (2) 1901697; 10.1183/13993003.01697-2019 Year: 2020
Comparison of three clinical probability methods among patients with suspected pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both? Source: Eur Respir J 2015; 46: 1551-1553 Year: 2015
Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 Year: 2017
Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018
Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021 Year: 2021
Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy Source: Eur Respir J 2016; 47: 690-691 Year: 2016
The evaluation of medication adherence in patients with pulmonary thromboembolism Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment Year: 2018
Comparison of three clinical scoring methods in patients with pulmonary thromboembolism Source: Annual Congress 2006 - Pulmonary embolism Year: 2006
Interpreting risk reduction in clinical trials for pulmonary arterial hypertension Source: Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018 Year: 2018
Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy? Source: Eur Respir J 2016; 47: 688-690 Year: 2016
The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
The comparison of three different clinical probability methods and the ECG score in patients with suspected venous thromboembolism Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007
Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005
Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021 Year: 2022
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018